Bafico, Anna; Liu, Guizhong; Goldin, Luba; Harris, Violaine; Aaronson, Stuart A. (2004). "An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells". Cancer Cell6 (5): 497–506. PMID15542433. doi:10.1016/j.ccr.2004.09.032.
Grivennikov, Sergei; Karin, Michael (2008). "Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?". Cancer Cell13 (1): 7–9. PMID18167335. doi:10.1016/j.ccr.2007.12.020.
Weigand, Melanie; Hantel, Pia; Kreienberg, Rolf; Waltenberger, Johannes (2005). "Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro". Angiogenesis8 (3): 197–204. PMID16328160. doi:10.1007/s10456-005-9010-0.
Mercurio, Arthur M; Bachelder, Robin E; Bates, Richard C; Chung, Jun (2004). "Autocrine signaling in carcinoma: VEGF and the α6β4 integrin". Seminars in Cancer Biology14 (2): 115–22. PMID15018895. doi:10.1016/j.semcancer.2003.09.016.
Wilson, Timothy R.; Lee, Diana Y.; Berry, Leanne; Shames, David S.; Settleman, Jeff (2011). "Neuregulin-1-Mediated Autocrine Signaling Underlies Sensitivity to HER2 Kinase Inhibitors in a Subset of Human Cancers". Cancer Cell20 (2): 158–72. PMID21840482. doi:10.1016/j.ccr.2011.07.011.
Yi, Eun Hee; Lee, Chang Seok; Lee, Jin-Ku; Lee, Young Ju; Shin, Min Kyung; Cho, Chung-Hyun; Kang, Keon Wook; Lee, Jung Weon; Han, Wonshik; Noh, D.-Y.; Kim, Y.-N.; Cho, I.-H.; Ye, S.-k. (2012). "STAT3-RANTES Autocrine Signaling is Essential for Tamoxifen Resistance in Human Breast Cancer Cells". Molecular Cancer Research11 (1): 31–42. PMID23074171. doi:10.1158/1541-7786.MCR-12-0217.
nih.gov
ncbi.nlm.nih.gov
Bafico, Anna; Liu, Guizhong; Goldin, Luba; Harris, Violaine; Aaronson, Stuart A. (2004). "An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells". Cancer Cell6 (5): 497–506. PMID15542433. doi:10.1016/j.ccr.2004.09.032.
Grivennikov, Sergei; Karin, Michael (2008). "Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?". Cancer Cell13 (1): 7–9. PMID18167335. doi:10.1016/j.ccr.2007.12.020.
Weigand, Melanie; Hantel, Pia; Kreienberg, Rolf; Waltenberger, Johannes (2005). "Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro". Angiogenesis8 (3): 197–204. PMID16328160. doi:10.1007/s10456-005-9010-0.
Mercurio, Arthur M; Bachelder, Robin E; Bates, Richard C; Chung, Jun (2004). "Autocrine signaling in carcinoma: VEGF and the α6β4 integrin". Seminars in Cancer Biology14 (2): 115–22. PMID15018895. doi:10.1016/j.semcancer.2003.09.016.
Wilson, Timothy R.; Lee, Diana Y.; Berry, Leanne; Shames, David S.; Settleman, Jeff (2011). "Neuregulin-1-Mediated Autocrine Signaling Underlies Sensitivity to HER2 Kinase Inhibitors in a Subset of Human Cancers". Cancer Cell20 (2): 158–72. PMID21840482. doi:10.1016/j.ccr.2011.07.011.
Yi, Eun Hee; Lee, Chang Seok; Lee, Jin-Ku; Lee, Young Ju; Shin, Min Kyung; Cho, Chung-Hyun; Kang, Keon Wook; Lee, Jung Weon; Han, Wonshik; Noh, D.-Y.; Kim, Y.-N.; Cho, I.-H.; Ye, S.-k. (2012). "STAT3-RANTES Autocrine Signaling is Essential for Tamoxifen Resistance in Human Breast Cancer Cells". Molecular Cancer Research11 (1): 31–42. PMID23074171. doi:10.1158/1541-7786.MCR-12-0217.